Health and Pharmaceutical Press Releases

2026-08-19 12:29 BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
2026-08-12 09:44 Align Technology Prevails in China Patent Infringement Action Against Angelalign
2026-08-11 16:02 BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
2026-08-11 13:08 Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping
2026-08-10 14:06 ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
2026-08-06 10:00 U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
2026-08-05 11:27 WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership
2026-08-05 11:23 LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care
2026-08-03 18:01 iKang Outpatient Deploys InterSystems TrakCare to Realize Health Management Vision
2026-07-31 13:00 White Paper Examines Early Clinical Development of B-Cell Depletion Therapies in Autoimmune Disease
2026-07-30 16:11 Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track
2026-07-30 15:48 VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System
2026-07-30 15:32 Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network
2026-07-29 13:09 Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
2026-07-24 15:41 Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results
2026-07-23 14:29 Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year
2026-07-22 15:11 Zayed Sustainability Prize’s Beyond2020 Initiative Strengthens Healthcare Resilience for Over 200,000 People in India
2026-07-22 14:43 SIAL Paris 2026: the Event That Sheds Light on and Accelerates the Global Agri-food Industry
2026-07-21 15:58 Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension
2026-07-21 15:46 HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong